Pipeline · Bill → Law
Step 1
Introduced
Apr 19, 2023
Step 2
Referred
Dec 17, 2024
Ways & Means
Step 3
Committee
Step 4
House floor
Step 5
Senate
Step 6
Resolve Changes
Step 7
Signed
SummaryCRS Summary
This bill establishes a tax credit for certain manufacturers of pharmaceuticals or medical products. Specifically, the bill establishes a tax credit for manufacturers of pharmaceuticals, active pharmaceutical ingredients, excipients (i.e., inactive ingredients), medical diagnostic devices, or personal protective equipment, if they are located in a designated distressed zone. The tax credit is equal to 25% of the manufacturer's production expenditures; the credit increases to 30% of expenditures if a substantial portion of the manufacturer's employees reside in a distressed zone. The bill defines distressed zone as an area that has been designated as a qualified opportunity zone by the Inte...
Timeline · 3 actions
Dec 17, 2024
Referred to the Subcommittee on Health.
Apr 19, 2023
Introduced in House
Apr 19, 2023
Referred to the House Committee on Ways and Means.